Exactech, Inc. (NASDAQ:EXAC) posted its quarterly earnings data on Monday. The medical equipment provider reported $0.20 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.23 by ($0.03), Yahoo Finance reports. Exactech had a return on equity of 7.29% and a net margin of 0.18%. The firm had revenue of $61.40 million during the quarter, compared to analyst estimates of $61.78 million.

Exactech (EXAC) opened at 41.85 on Wednesday. The firm has a market capitalization of $600.46 million, a PE ratio of 804.81 and a beta of 1.01. Exactech has a one year low of $22.40 and a one year high of $42.55. The stock’s 50 day moving average price is $34.09 and its 200 day moving average price is $30.94.

Several equities research analysts recently issued reports on EXAC shares. BidaskClub cut Exactech from a “hold” rating to a “sell” rating in a report on Monday, July 31st. Gabelli cut Exactech from a “buy” rating to a “hold” rating in a report on Tuesday, October 24th. Robert W. Baird set a $34.00 target price on Exactech and gave the stock a “buy” rating in a report on Sunday, October 15th. Zacks Investment Research cut Exactech from a “hold” rating to a “sell” rating in a report on Wednesday, October 25th. Finally, Sidoti cut Exactech from a “buy” rating to a “neutral” rating in a report on Monday, October 23rd. One research analyst has rated the stock with a sell rating and four have issued a hold rating to the company. Exactech has an average rating of “Hold” and an average target price of $42.00.

In other news, Director Fern Watts sold 1,013 shares of the firm’s stock in a transaction that occurred on Tuesday, August 8th. The shares were sold at an average price of $29.04, for a total transaction of $29,417.52. Following the completion of the transaction, the director now directly owns 4,727 shares of the company’s stock, valued at approximately $137,272.08. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 28.30% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Exactech, Inc. (EXAC) Announces Quarterly Earnings Results, Misses Expectations By $0.03 EPS” was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://theolympiareport.com/2017/11/01/exactech-inc-exac-announces-quarterly-earnings-results-misses-expectations-by-0-03-eps.html.

About Exactech

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Earnings History for Exactech (NASDAQ:EXAC)

Receive News & Ratings for Exactech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.